Page 23 - Glucose Monitoring Devices
P. 23

18     CHAPTER 1 Introduction to SMBG




                         Table 1.1 Current clinical guidelines and consensus statements for self-monitoring
                         of blood glucose in type 2 diabetes.dcont’d
                          Guideline                     Recommendations
                                                         o checking that the person knows how to
                                                           interpret the blood glucose results and what
                                                           action to take
                                                         o the impact on the person’s quality of life
                                                         o the continued benefit to the person
                                                         o the equipment used.
                          Diabetes UK f                 • SMBG in people with Ttype 2 diabetes on
                                                         insulin and medication that carries a risk of
                                                         hypoglycemia should be regarded as an
                                                         integral part of treatment and should not be
                                                         restricted.
                                                        • For people not in these treatment groups,
                                                         SMBG should be available based on an
                                                         individual assessment of need. Arbitrary
                                                         withdrawal of SMBG in those who clearly
                                                         benefit from doing so should not occur. People
                                                         have the right to ask for a review and challenge
                                                         these decisions if necessary.
                                                        • DVLA guidance requires some treatment
                                                         groups to conduct testing for licensing and
                                                         safety reasons.
                                                        • Use and frequency of testing, choice of meter,
                                                         and target blood glucose should be agreed
                                                         between the person with diabetes and their
                                                         healthcare team. Local medicine management
                                                         policies should allow sufficient choice and
                                                         flexibility per individual circumstances to be
                                                         taken into account.
                                                        • Structured assessment of self-monitoring
                                                         skills, the equipment used, and the quality and
                                                         use made of the results obtained should be
                                                         performed at least annually, or more frequently
                                                         according to need.
                                                        • SMBG should be integrated with a care
                                                         package, accompanied by education, and
                                                         should enable the individual to either interpret
                                                         and adjust treatment accordingly or inform their
                                                         healthcare team.
                          AACE/ACE Outpatient Glucose   Type 2dReceiving insulin/sulfonylureas, glinides
                          Monitoring Consensus Statement g  • Structured BGM is recommended.
                                                        • BGM in patients on intensive insulin: fasting,
                                                         premeal, bedtime, and periodically in the
                                                         middle of the night.
                                                        • BGM in patients on insulin   other diabetes
                                                         medication: at a minimum, when fasting and at
                                                         bedtime.
   18   19   20   21   22   23   24   25   26   27   28